Patent details

Basic Information

Publication number:

EP2550965

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP120073275

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Ceramide derivatives for treating polycystic kidney disease

French Title of Invention:

Dérivés de céramide pour le traitement de la polykystose rénale

German Title of Invention:

Ceramidderivate zur Behandlung polyzystischer Nierenerkrankung

SPC Number:

Dates

Filing date:

03/10/2008

Grant date:

16/01/2019

EP Publication Date:

30/01/2013

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

16/01/2019

EP B1 Publication Date:

16/01/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

03/10/2019

Expiration date:

03/10/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

09/01/2019

 

 

Name:

Genzyme Corporation

Address:

50 Binney Street, Cambridge, MA 02142, United States (US)

Inventor

1

Name:

Natoli, Thomas A.

Address:

United States (US)

2

Name:

Yew, Nelson S.

Address:

United States (US)

3

Name:

Leonard, John P.

Address:

United States (US)

4

Name:

Ibraghinov-Beskrovnaya, Oxana

Address:

United States (US)

5

Name:

Cheng, Seng H.

Address:

United States (US)

Priority

Priority Number:

997803 P

Priority Date:

05/10/2007

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/4025; A61P 13/02;

Publication

European Patent Bulletin

Issue number:

201903

Publication date:

16/01/2019

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages